Suppr超能文献

新辅助动脉内化疗后行全腹腔镜根治性宫颈切除术治疗 IB1 期宫颈癌。

Neoadjuvant intra-arterial chemotherapy followed by total laparoscopic radical trachelectomy in stage IB1 cervical cancer.

机构信息

Department of Obstetrics and Gynecology, Chao-yang Hospital, Capital Medical University, Beijing, People's Republic of China.

Department of Obstetrics and Gynecology, China Aerospace Science & Industry Corporation 731 Hospital, Beijing, People's Republic of China.

出版信息

Fertil Steril. 2014 Mar;101(3):812-7. doi: 10.1016/j.fertnstert.2013.12.001. Epub 2014 Jan 16.

Abstract

OBJECTIVE

To support the feasibility and safety of neoadjuvant intra-arterial chemotherapy followed by total laparoscopic radical trachelectomy in stage IB1 cervical cancer with tumor larger than 2 cm.

DESIGN

A retrospective study.

SETTING

University-affiliated gynecologic oncology department.

PATIENT(S): Patients with stage IB1 cervical cancer with tumor size larger than 2 cm who wish to preserve fertility.

INTERVENTION(S): Neoadjuvant intra-arterial chemotherapy followed by laparoscopic radical trachelectomy.

MAIN OUTCOMES MEASURE(S): Data regarding neoadjuvant chemotherapy operational time, blood loss, recurrence, and subsequent pregnancies were recorded. Other published reports on neoadjuvant chemotherapy followed by radical trachelectomy were reviewed.

RESULT(S): Seven patients had a laparoscopic radical trachelectomy after neoadjuvant intra-arterial chemotherapy for stage IB1 cervical cancer. Median tumor diameter evaluated by colposcopy was 3.3 cm (range, 2.5-4.0 cm), tumor histotype was all squamous. All patients showed complete or partial response to neoadjuvant chemotherapy, and they were all treated with total laparoscopic radical trachelectomy. One patient had no menses after treatment. After a median 66 months (range, 12-90 months) of follow-up time, no recurrence was observed. Only four patients attempted to conceive and two succeeded.

CONCLUSION(S): Neoadjuvant intra-arterial chemotherapy followed by total laparoscopic radical trachelectomy may become a useful option for women with cervical cancer with a tumor size larger than 2 cm who wish to preserve fertility. Ovarian protection warrants further investigation.

摘要

目的

支持在肿瘤大于 2cm 的 IB1 期宫颈癌中,先行新辅助动脉内化疗,再行完全腹腔镜根治性宫颈切除术的可行性和安全性。

设计

回顾性研究。

地点

大学附属妇科肿瘤学系。

患者

希望保留生育能力的肿瘤大于 2cm 的 IB1 期宫颈癌患者。

干预措施

新辅助动脉内化疗后行腹腔镜根治性宫颈切除术。

主要观察指标

记录新辅助化疗手术时间、出血量、复发和后续妊娠的数据。还回顾了其他关于新辅助化疗后根治性宫颈切除术的已发表报告。

结果

7 例 IB1 期宫颈癌患者在新辅助动脉内化疗后行腹腔镜根治性宫颈切除术。阴道镜评估的中位肿瘤直径为 3.3cm(范围,2.5-4.0cm),肿瘤组织学类型均为鳞癌。所有患者对新辅助化疗均有完全或部分反应,均行完全腹腔镜根治性宫颈切除术。1 例患者治疗后无月经。中位随访时间为 66 个月(范围,12-90 个月),无复发。仅 4 例患者尝试妊娠,2 例成功。

结论

对于希望保留生育能力的肿瘤大于 2cm 的宫颈癌患者,先行新辅助动脉内化疗,再行完全腹腔镜根治性宫颈切除术可能成为一种有用的选择。卵巢保护需要进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验